Tag: genetics testing

November 13, 2018

CRISPR Trials to Watch in 2018

CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
April 19, 2018

Genetics Update: Q1 in Review

With Q1 2018 officially in the books, here the Investing News Network takes a look back at what some of...
February 22, 2017

NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter...
November 20, 2016

5 Top NASDAQ Biotech Stocks: Ocular Therapeutix Gains Near 60 Percent

The week's top gainer was Ocular Therapeutix, followed by Cara Therapeutics, Immunomedics, Rockwell Medical and Array BioPharma.
November 13, 2016

5 Top NASDAQ Biotech Stocks: PTC Therapeutics Gains 88 Percent

Last week's top gainer was PTC Therapeutics followed by Cogentix Medical, Concordia International, Galectin Therapeutics and XOMA.
November 6, 2016

5 Top NASDAQ Biotech Stocks: AveXis, Inc. Leads

Last week's top gainer was AveXis, Inc. followed by Heska Corp., Corcept Therapeutics, Atara Biotherapeutics and Seattle Genetics Inc.
October 30, 2016

5 Top NASDAQ Biotech Stocks: Alexion Pharmaceuticals Leads

Last week's top gainer was Alexion Pharmaceuticals, followed by LeMaitre Vascular, NeoGenomics Inc, United Therapeutics Corp. and Mesa Laboratories.